NT-proBNP Assay Kit CLIA
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 06974521001584
- Basic UDI-DI Code
- B-06974521001584
- Reference
- SUPM039072
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Shenzhen Superbio Technology Co.,Ltd.
Additional Description
This kit is used for in vitro quantitative detection of N terminal atrial natriuretic peptide (NT-proBNP) in human serum, plasma or whole blood samples. Determination of NT-proBNP can be used as an auxiliary means for diagnosis of patients suspected of having congestive heart-failure and monitoring mild cardiac dysfunction. The test also can help evaluate the severity of patients with congestive heart-failure. It can be further used for risk rating of acute coronary syndrome and congestive heart-failure and treatment and monitoring of patients with left ventricular dysfunction.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W01021301 | BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES) |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).